BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24339287)

  • 1. Efficacy of short-term growth hormone treatment in prepubertal children with idiopathic short stature.
    Kim HS; Yang SW; Yoo HW; Suh BK; Ko CW; Chung WY; Lee KH; Hwang JS; Ji HJ; Ahn H; Kim DH
    Yonsei Med J; 2014 Jan; 55(1):53-60. PubMed ID: 24339287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency.
    van Doorn J; Ringeling AM; Rikken B; van Buul-Offers SC
    Horm Res; 2001; 55(3):147-54. PubMed ID: 11549877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial.
    Kim J; Suh BK; Ko CW; Lee KH; Shin CH; Hwang JS; Kim HS; Chung WY; Kim CJ; Han HS; Kwon NY; Cho SY; Yoo HW; Jin DK
    J Endocrinol Invest; 2018 Apr; 41(4):475-483. PubMed ID: 29103133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiology of short stature in Indian children and an assessment of the growth hormone-insulin-like growth factor axis in children with idiopathic short stature.
    Kumar A; Pal A; Kalaivani M; Gupta N; Jain V
    J Pediatr Endocrinol Metab; 2018 Sep; 31(9):1009-1017. PubMed ID: 30130251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature.
    Blair JC; Camacho-Hübner C; Miraki Moud F; Rosberg S; Burren C; Lim S; Clayton PE; Bjarnason R; Albertsson-Wikland K; Savage MO
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):163-8; discussion 161-2. PubMed ID: 14725676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
    Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of insulin-like growth factor (IGF)-I and IGF binding protein-3 generation test in short stature.
    Darendeliler F; Ocal C; Baş F
    J Pediatr Endocrinol Metab; 2005 May; 18(5):443-52. PubMed ID: 15921173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: individual capacity of IGF-I generation after high-dose GH treatment determines the growth response to GH.
    Kamp GA; Zwinderman AH; Van Doorn J; Hackeng W; Frölich M; Schönau E; Wit JM
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):315-25. PubMed ID: 12201823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of zinc supplementation on growth hormone secretion, IGF-I, IGFBP-3, somatomedin generation, alkaline phosphatase, osteocalcin and growth in prepubertal children with idiopathic short stature.
    Imamoğlu S; Bereket A; Turan S; Taga Y; Haklar G
    J Pediatr Endocrinol Metab; 2005 Jan; 18(1):69-74. PubMed ID: 15679071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
    Rogol AD; Blethen SL; Sy JP; Veldhuis JD
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):229-37. PubMed ID: 12580940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
    Liu HJ; Wang LH; Chen L
    Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
    Lanes R; Gunczler P; Esaa S; Weisinger JR
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):725-30. PubMed ID: 12460321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
    Ballerini MG; Braslavsky D; Scaglia PA; Keselman A; Rodríguez ME; Martínez A; Freire AV; Domené HM; Jasper HG; Bergadá I; Ropelato MG
    Horm Res Paediatr; 2017; 88(5):354-363. PubMed ID: 28926833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of free insulin-like growth factor (IGF)-I and IGF-binding protein-1 in prepubertal children with idiopathic short stature.
    Kamoda T; Saitoh H; Hirano T; Matsui A
    Clin Endocrinol (Oxf); 2000 Dec; 53(6):683-8. PubMed ID: 11155089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting bone age maturation during 3 years of growth hormone treatment in patients with idiopathic growth hormone deficiency and idiopathic short stature: Analysis of data from the LG growth study.
    Kang MJ; Kim EY; Shim YS; Jeong HR; Lee HJ; Yang S; Hwang IT
    Medicine (Baltimore); 2019 Apr; 98(14):e14962. PubMed ID: 30946320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.